{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:05:42Z","timestamp":1786359942902,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T00:00:00Z","timestamp":1634428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T00:00:00Z","timestamp":1634428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Remnant cholesterol (RC) mediates the progression of coronary artery disease, diabetic complications, hypertension, and chronic kidney disease. Limited information is available on the association of RC with nonalcoholic fatty liver disease (NAFLD). This study aimed to explore whether RC can be used to independently evaluate the risk of NAFLD in the general population and to analyze the predictive value of RC for NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included 14,251 subjects enrolled in a health screening program. NAFLD was diagnosed by ultrasound, and the association of RC with NAFLD was assessed using the receiver operating characteristic (ROC) curve and logistic regression equation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Subjects with elevated RC had a significantly higher risk of developing NAFLD after fully adjusting for potential confounding factors (OR 1.77 per SD increase, 95% CI 1.64\u20131.91, <jats:italic>P<\/jats:italic> trend&lt;\u20090.001). There were significant differences in this association among sex, BMI and age stratification. Compared with men, women were facing a higher risk of RC-related NAFLD. Compared with people with normal BMI, overweight and obesity, the risk of RC-related NAFLD was higher in thin people. In different age stratifications, when RC increased, young people had a higher risk of developing NAFLD than other age groups. Additionally, ROC analysis results showed that among all lipid parameters, the AUC of RC was the largest (women: 0.81; men: 0.74), and the best threshold for predicting NAFLD was 0.54 in women and 0.63 in men.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results obtained from this study indicate that (1) in the general population, RC is independently associated with NAFLD but not with other risk factors. (2) Compared with traditional lipid parameters, RC has a better predictive ability for NAFLD in men.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01573-y","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T07:05:35Z","timestamp":1634454335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yang","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjia","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-4920","authenticated-orcid":false,"given":"Guobo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,17]]},"reference":[{"issue":"28","key":"1573_CR1","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107 S, Luli\u0107 D, \u0160timac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330\u20137. https:\/\/doi.org\/10.3748\/wjg.v20.i28.9330.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"1573_CR2","doi-asserted-by":"publisher","first-page":"25168","DOI":"10.3390\/ijms161025168","volume":"16","author":"MC Hernandez-Rodas","year":"2015","unstructured":"Hernandez-Rodas MC, Valenzuela R, Videla LA. Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int J Mol Sci. 2015;16(10):25168\u201398. https:\/\/doi.org\/10.3390\/ijms161025168.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1573_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"16","key":"1573_CR4","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.4155\/fmc-2019-0003","volume":"11","author":"S Ballestri","year":"2019","unstructured":"Ballestri S, Mantovani A, Nascimbeni F, Lugari S, Lonardo A. Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease. Future Med Chem. 2019;11(16):2171\u201392. https:\/\/doi.org\/10.4155\/fmc-2019-0003.","journal-title":"Future Med Chem"},{"issue":"1","key":"1573_CR5","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1):S47\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","journal-title":"J Hepatol"},{"issue":"6","key":"1573_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884.","journal-title":"Gut"},{"issue":"8","key":"1573_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65(8):1109\u201323. https:\/\/doi.org\/10.1016\/j.metabol.2016.05.003.","journal-title":"Metabolism"},{"issue":"5","key":"1573_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5(5):1544\u201360. https:\/\/doi.org\/10.3390\/nu5051544.","journal-title":"Nutrients"},{"issue":"1","key":"1573_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","volume":"3","author":"QQ Zhang","year":"2015","unstructured":"Zhang QQ, Lu LG. Nonalcoholic fatty liver disease: dyslipidemia, risk for cardiovascular complications, and treatment strategy. J Clin Transl Hepatol. 2015;3(1):78\u201384. https:\/\/doi.org\/10.14218\/JCTH.2014.00037.","journal-title":"J Clin Transl Hepatol"},{"issue":"12","key":"1573_CR10","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2337\/diacare.27.12.3009","volume":"27","author":"ZT Bloomgarden","year":"2004","unstructured":"Bloomgarden ZT. Dyslipidemia and the metabolic syndrome. Diabetes Care. 2004;27(12):3009\u201316. https:\/\/doi.org\/10.2337\/diacare.27.12.3009.","journal-title":"Diabetes Care"},{"issue":"4","key":"1573_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","volume":"26","author":"SM Grundy","year":"2016","unstructured":"Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364\u201373. https:\/\/doi.org\/10.1016\/j.tcm.2015.10.004.","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"1573_CR12","doi-asserted-by":"publisher","first-page":"e002765","DOI":"10.1161\/JAHA.115.002765","volume":"5","author":"PH Joshi","year":"2016","unstructured":"Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS, et al. Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson heart and Framingham offspring cohort studies. J Am Heart Assoc. 2016;5(5):e002765. https:\/\/doi.org\/10.1161\/JAHA.115.002765.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1573_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-021-01490-0","volume":"20","author":"K Li","year":"2021","unstructured":"Li K, Fan F, Zheng B, Jia J, Liu B, Liu J, et al. Associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: a cross-sectional study. Lipids Health Dis. 2021;20(1):60. https:\/\/doi.org\/10.1186\/s12944-021-01490-0.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1573_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12944-017-0410-0","volume":"16","author":"LF Hong","year":"2017","unstructured":"Hong LF, Yan XN, Lu ZH, Fan Y, Ye F, Wu Q, et al. Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease. Lipids Health Dis. 2017;16(1):7. https:\/\/doi.org\/10.1186\/s12944-017-0410-0.","journal-title":"Lipids Health Dis"},{"key":"1573_CR15","doi-asserted-by":"publisher","unstructured":"Yan P, Xu Y, Miao Y, Bai X, Wu Y, Tang Q, et al. Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study. Acta Diabetol. 2021. https:\/\/doi.org\/10.1007\/s00592-021-01765-z.","DOI":"10.1007\/s00592-021-01765-z"},{"issue":"1","key":"1573_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12933-020-01076-7","volume":"19","author":"YX Cao","year":"2020","unstructured":"Cao YX, Zhang HW, Jin JL, Liu HH, Zhang Y, Gao Y, et al. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol. 2020;19(1):104. https:\/\/doi.org\/10.1186\/s12933-020-01076-7.","journal-title":"Cardiovasc Diabetol"},{"key":"1573_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes. 2019;43:139\u201348.","journal-title":"Int J Obes"},{"key":"1573_CR18","doi-asserted-by":"publisher","unstructured":"Okamura T, et al. Data from: ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Dryad, Dataset. 2019. https:\/\/doi.org\/10.5061\/dryad.8q0p192.","DOI":"10.5061\/dryad.8q0p192"},{"issue":"4","key":"1573_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3350\/cmh.2020.0163","volume":"26","author":"JH Choi","year":"2020","unstructured":"Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26(4):662\u20139. https:\/\/doi.org\/10.3350\/cmh.2020.0163.","journal-title":"Clin Mol Hepatol"},{"issue":"9403","key":"1573_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert","year":"2004","unstructured":"Expert WHO. Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3.","journal-title":"Lancet"},{"issue":"1","key":"1573_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1476-511X-9-52","volume":"9","author":"Y Chen","year":"2010","unstructured":"Chen Y, Zhang X, Pan B, Jin X, Yao H, Chen B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010;9(1):52. https:\/\/doi.org\/10.1186\/1476-511X-9-52.","journal-title":"Lipids Health Dis"},{"issue":"9943","key":"1573_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)61177-6.","journal-title":"Lancet"},{"issue":"12","key":"1573_CR23","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708\u201315. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01526.x.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1573_CR24","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/S1473-3099(16)30082-2","volume":"16","author":"EJA Fitchett","year":"2016","unstructured":"Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16(10):e202\u201313. https:\/\/doi.org\/10.1016\/S1473-3099(16)30082-2.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"1573_CR25","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500\u201324. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.014.","journal-title":"Int J Surg"},{"issue":"6","key":"1573_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72(6):558\u201369. https:\/\/doi.org\/10.4097\/kja.19087.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"1573_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59(2):713\u201323. https:\/\/doi.org\/10.1002\/hep.26672.","journal-title":"Hepatology"},{"issue":"11","key":"1573_CR28","doi-asserted-by":"publisher","first-page":"e0243068","DOI":"10.1371\/journal.pone.0243068","volume":"15","author":"Y Zou","year":"2020","unstructured":"Zou Y, Sheng G, Yu M, Xie G. The association between triglycerides and ectopic fat obesity: an inverted U-shaped curve. PLoS One. 2020;15(11):e0243068. https:\/\/doi.org\/10.1371\/journal.pone.0243068.","journal-title":"PLoS One"},{"issue":"6","key":"1573_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbatesliver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45(6):1366\u201374. https:\/\/doi.org\/10.1002\/hep.21655.","journal-title":"Hepatology"},{"key":"1573_CR30","doi-asserted-by":"publisher","first-page":"783976","DOI":"10.1155\/2011\/783976","volume":"2011","author":"K Fon Tacer","year":"2011","unstructured":"Fon Tacer K, Rozman D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation. J Lipids. 2011;2011:783976.","journal-title":"J Lipids"},{"issue":"5","key":"1573_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","volume":"15","author":"H-K Min","year":"2012","unstructured":"Min H-K, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012;15(5):665\u201374. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.004.","journal-title":"Cell Metab"},{"key":"1573_CR32","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","volume":"141","author":"DM Van Rooyen","year":"2011","unstructured":"Van Rooyen DM, Larter CZ, Haigh WG, Yeh MM, Ioannou G, Kuver R, et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology. 2011;141:1393\u2013403 1403.e1\u20135.","journal-title":"Gastroenterology"},{"key":"1573_CR33","doi-asserted-by":"publisher","first-page":"9895176","DOI":"10.1155\/2016\/9895176","volume":"2016","author":"N Nu\u00f1o-L\u00e1mbarri","year":"2016","unstructured":"Nu\u00f1o-L\u00e1mbarri N, Dom\u00ednguez-P\u00e9rez M, Baulies-Domenech A, Monte MJ, Marin JJ, Rosales-Cruz P, et al. Liver cholesterol overload aggravates obstructive cholestasis by inducing oxidative stress and premature death in mice. Oxidative Med Cell Longev. 2016;2016:9895176\u201313. https:\/\/doi.org\/10.1155\/2016\/9895176.","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"1573_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bcp.2013.03.016","volume":"86","author":"S Ducheix","year":"2013","unstructured":"Ducheix S, Montagner A, Theodorou V, Ferrier L, Guillou H. The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease. Biochem Pharmacol. 2013;86(1):96\u2013105. https:\/\/doi.org\/10.1016\/j.bcp.2013.03.016.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"1573_CR35","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/01.CIR.0000125278.58527.F3","volume":"109","author":"TB Twickler","year":"2004","unstructured":"Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation. 2004;109(16):1918\u201325. https:\/\/doi.org\/10.1161\/01.CIR.0000125278.58527.F3.","journal-title":"Circulation"},{"issue":"12","key":"1573_CR36","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","volume":"128","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128(12):1298\u2013309. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003008.","journal-title":"Circulation"},{"issue":"11","key":"1573_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/jcm7110378","volume":"7","author":"D Pastori","year":"2018","unstructured":"Pastori D, Baratta F, Novo M, Cocomello N, Violi F, Angelico F, et al. Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease. J Clin Med. 2018;7(11):378. https:\/\/doi.org\/10.3390\/jcm7110378.","journal-title":"J Clin Med"},{"issue":"6","key":"1573_CR38","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.jhepr.2020.100150","volume":"2","author":"J Chin","year":"2020","unstructured":"Chin J, Mori TA, Adams LA, Beilin LJ, Huang RC, Olynyk JK, et al. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. JHEP Rep. 2020;2(6):100150. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100150.","journal-title":"JHEP Rep"},{"issue":"6","key":"1573_CR39","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/nu12061674","volume":"12","author":"A Campanella","year":"2020","unstructured":"Campanella A, Iacovazzi PA, Misciagna G, Bonfiglio C, Mirizzi A, Franco I, et al. The effect of three Mediterranean diets on remnant cholesterol and non-alcoholic fatty liver disease: a secondary analysis. Nutrients. 2020;12(6):1674. https:\/\/doi.org\/10.3390\/nu12061674.","journal-title":"Nutrients"},{"issue":"4","key":"1573_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","volume":"46","author":"M Cnop","year":"2003","unstructured":"Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459\u201369. https:\/\/doi.org\/10.1007\/s00125-003-1074-z.","journal-title":"Diabetologia"},{"issue":"1","key":"1573_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/09513599809024970","volume":"12","author":"A Nasr","year":"1998","unstructured":"Nasr A, Breckwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol. 1998;12(1):43\u201359. https:\/\/doi.org\/10.3109\/09513599809024970.","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"1573_CR42","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/ajg.2012.314","volume":"107","author":"YM Kwon","year":"2012","unstructured":"Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107(12):1852\u20138. https:\/\/doi.org\/10.1038\/ajg.2012.314.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1573_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12944-020-01419-z","volume":"19","author":"Y Zou","year":"2020","unstructured":"Zou Y, Zhong L, Hu C, Sheng G. Association between the alanine aminotransferase\/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids Health Dis. 2020;19(1):245. https:\/\/doi.org\/10.1186\/s12944-020-01419-z.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1573_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12876-021-01824-3","volume":"21","author":"G Sheng","year":"2021","unstructured":"Sheng G, Xie Q, Wang R, Hu C, Zhong M, Zou Y. Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterol. 2021;21(1):239. https:\/\/doi.org\/10.1186\/s12876-021-01824-3.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"1573_CR45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(20)30077-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"1573_CR46","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/liv.13993","volume":"39","author":"DJ Cuthbertson","year":"2019","unstructured":"Cuthbertson DJ, Brown E, Koskinen J, Magnussen CG, Hutri-K\u00e4h\u00f6nen N, Sabin M, et al. Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood. Liver Int. 2019;39(6):1147\u201354. https:\/\/doi.org\/10.1111\/liv.13993.","journal-title":"Liver Int"},{"key":"1573_CR47","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1097\/AOG.0000000000001313","volume":"127","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Adolescent Health Care","year":"2016","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Adolescent Health Care. Committee Opinion No. 653: Concerns Regarding Social Media and Health Issues in Adolescents and Young Adults. Obstet Gynecol. 2016;127:e62\u20135.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1573_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/07420528.2018.1563094","volume":"36","author":"DM McMahon","year":"2019","unstructured":"McMahon DM, Burch JB, Youngstedt SD, Wirth MD, Hardin JW, Hurley TG, et al. Relationships between chronotype, social jetlag, sleep, obesity and blood pressure in healthy young adults. Chronobiol Int. 2019;36(4):493\u2013509. https:\/\/doi.org\/10.1080\/07420528.2018.1563094.","journal-title":"Chronobiol Int"},{"issue":"40","key":"1573_CR49","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25(40):6053\u201362. https:\/\/doi.org\/10.3748\/wjg.v25.i40.6053.","journal-title":"World J Gastroenterol"},{"issue":"7040","key":"1573_CR50","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","volume":"312","author":"N Black","year":"1996","unstructured":"Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312(7040):1215\u20138. https:\/\/doi.org\/10.1136\/bmj.312.7040.1215.","journal-title":"BMJ"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01573-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01573-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T07:08:07Z","timestamp":1634454487000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01573-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,17]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1573"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01573-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,17]]},"assertion":[{"value":"22 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the authorization of the ethics committee of Murakami Memorial Hospital has been obtained in the previous study, this study does not need to be submitted for ethical approval again.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}